UH Cancer IRB

Review of Cancer Research

University Hospitals Case Medical Center has formed a new committee, the UH Cancer IRB (OHRP registration number IRB00008600), which reviews all cancer or cancer-related research protocols conducted at UH. This committee will function under the UH Federalwide Assurance, (number FWA00003937), and will meet on a regular schedule.

For information about the new UH Cancer IRB, or to learn more about submitting your cancer or cancer-related research study for review, please call the UH Case Medical Center IRB Administration Office at 216-844-1529.

Meeting Dates and Submission Deadlines

The Cancer IRB meets the 2nd and 4th Thursdays of the month (except holidays) at 2:30 p.m. The deadline for protocol submission is 10 days before the meeting date.

• Cancer IRB Meeting Dates 2012 (PDF)
• IRB Roster – C Committee (Cancer) (PDF) (2012)

Policies Specific to UH Cancer IRB

• Reporting of Adverse Events and Unanticipated Problems (12/2011)
• Reporting of Protocol Deviations (12/2011)

IRB Administration Office Staff

Rachel Egler, MD, IRB Chair
Joseph Baar, MD, IRB Vice Chair
Joseph Gibbons, MD, IRB Vice Chair

Philip A. Cola, MA
Vice-President, Research and Technology
IRB Administrative Office Head
Phone: 216-844-5568
Email: Philip.Cola@UHhospitals.org

Carol Fedor, RN, ND, CCRC
Clinical Research Manager
Phone: 216-844-5524
Email: Carol.Fedor@UHhospitals.org

Cheryl Gipson
Human Subjects Protection Specialist
Phone: 216.844.7829
Email: Cheryl.Gipson@UHhospitals.org

April Smith
Institutional Review Coordinator
Phone: 216.844.7826
Email: April.Smith@UHhospitals.org